Home/Search
2021 Scientific Sessions
2021 Scientific Sessions: Alphabetical Content Listing
A Little Help From My Friends
Discussion
Discussion
Discussion
Discussion
I Can See Clearly Now: How Noninvasive Imagers Can Help You See The Way
William Border
I’ve Got You, Babe: How Neonatologists and Invasive Cardiologists Are Collaborating on Our Smallest Patients
Carl Backes, MD
Stayin’ Alive: What the Intensivist Can Do to Help Keep the Cath Lab Safe
David S Cooper, MD, MPH
We Can Work It Out: How Obstetricians and Interventional Cardiologists Can Change the Course of Heart Disease in Utero
Marjorie Treadwell
Welcoming Remarks
Daniel H. Gruenstein, M.D.
You’ve Got a Friend in Me: Congenital Heart Surgeons and Interventional Cardiologists (Should) Have a Symbiotic Relationship
Emile A. Bacha, M.D.
A New Look at Intravenous Platelet Inhibitors in the Cath Lab
ACS PCI (Case #1) With Panel Discussion: To Pre-load or Not to Pre-load, That Is the Question
Deepak L. Bhatt, M.D., M.P.H., MSCAI
Complex PCI (Case #2) With Panel Discussion: PCI in Complex Stable CAD
Suzanne J. Baron, M.D., FSCAI
IV Platelet Inhibition During High-risk PCI: Which Patients Benefit the Most?
Michelle O'Donoghue, MD, MPH
IV Platelet Inhibition for Bridging: A When-To and How-To Guide
George D. Dangas, M.D., Ph.D., MSCAI
IV Platelet Inhibition in Cardiogenic Shock: Should We Be Using in All Shock Patients?
Babar B Basir, DO, FSCAI
Panel Discussion
Welcoming Remarks
Srihari S. Naidu, MD, FSCAI
A Patient-Centered Approach to Optimizing DAPT Post-PCI
A Historical Review of Data in DAPT duration
Roxana Mehran, M.D., MSCAI
Panel Discussion
Real World Implications
Robert W. Yeh, M.D., FSCAI
Welcome and Introductions
Roxana Mehran, M.D., MSCAI
What Does the Data Tells us About HBR Patients and Complex Subsets?
Kathleen Kearney, M.D., FSCAI
ABCs of CTO
ABC of Antegrade Dissection Reentry
Katherine Kunkel, M.D., FSCAI
ABC of Retrograde CTO
Arasi Maran, M.D., FSCAI
Create a Lean, Mean CTO Cart
Allison Barbara Hall, M.D.
Hard Stops
William L. Lombardi, M.D., FSCAI
My First CTO Cases
Rhian E. Davies, DO MS, FSCAI
Welcoming Remarks
Dimitrios Karmpaliotis, M.D., FSCAI
ACHD/Structural Session—Creative Applications of Current Valve Technology
Catheterization in the Adult With a Single Ventricle: When to Stick and When to Twist?
John D. Thomson, M.D., FSCAI
Heart Failure in ACHD Patients: What Are the Transcatheter Options for the Future?
Vasiliki Vivian Dimas, M.D., FSCAI
Is Surgical Pulmonary Valve Replacement a Thing of the Past?
Jonathan McGuinness, MD, PhD
Risk Scoring for ACHD Catheterization—Does it Help in the Real World?
Nathan W. Taggart, M.D., FSCAI
Tricuspid and Mitral Valve Interventions in ACHD Patients
Thomas K. Jones, M.D., MSCAI
Welcoming Remarks
Eric Horlick, M.D., MSCAI
Who, Where, and How: Complex Adult Congenital Catheterization—What Is the Ideal Service Model?
Jamil A. Aboulhosn, M.D., FSCAI
Acute Kidney Injury in Coronary and Peripheral Settings
Foundations: Clinical Considerations and Healthcare Costs
Arnold H. Seto, MD, MPA, FSCAI
Panel Discussion
Renal Considerations in Complex and High-Risk Coronary Interventions
Emmanouil S. Brilakis, MD, PhD, FSCAI
Renal Considerations in the Patient Undergoing Peripheral Vascular Procedures
Amit P. Amin, MD, MSc, MBA
TAVR and Renal Disease
Shweta Bansal, MD
Welcoming Remarks
Anand Prasad, M.D., FSCAI
Advanced Cardiac Imaging
How Can Cardiac MRI Be Incorporated Into Your Valve Program?
Joao L. Cavalcante, M.D.
Interventional MRI for the New-Age Structural Interventionalist
Toby Rogers, MD
Intraprocedural Guidance With Fusion Imaging for Inflow Valve Therapies: A Strategy of Optimization
Robert A Quaife, MD
When the Case Is Over … How to Evaluate Post-Procedurally and Challenges for the Second and Third Intervention
Rebecca Tung Hahn, M.D.
Advanced Concepts in TAVR: Cusp Overlap Techniques in Complex Anatomies
Advanced Cusp Overlap Case—Bicuspid Anatomy
Kendra J. Grubb, M.D.
Advanced Cusp Overlap Case—TAV-in-SAV
James E. Harvey, M.D., FSCAI
Discussion
Discussion
Discussion
Global Experience and Data Supporting Cusp Overlap
Hemal Gada, M.D., FSCAI
Panel Discussion
Welcome and Introductions
Steven J. Yakubov, M.D., MSCAI
What the Data Tells Us: Discussing OPTIMIZE PRO
Steven J. Yakubov, M.D., MSCAI
Advanced Topics in ASD/PFO and LAA Closure: Optimizing Your Skill Sets
Device Embolization: How to Avoid/How to Retrieve
David T. Balzer, M.D., MSCAI
LAAC Step by Step: Cutting Edge Devices
Jacqueline Saw, M.D., FSCAI
PFOs: Indications Beyond Stroke Prevention
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
Special Cases in PFO Closure: Managing Afib and Hypercoagulable Patients
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
TEE vs ICE in LAAC
Mukta C. Srivastava, M.D.
Algorithms for the Cath Lab: How to Apply to the Individual Patient
Avoiding Bleeding in the Cath Lab: Optimizing Vascular Access and Anticoagulation Protocols
William F. Penny, M.D., FSCAI
Bed to Balloon Time: Expediting Inpatient STEMI Care
Alexander Craig Fanaroff, MD, MHS
Cardiac Arrest and When to Utilize the Cath Lab
Grace Ayafor, M.D., FSCAI
Culprit Only vs. Complete Revascularization in the STEMI Patient With and Without Cardiogenic Shock
Konstantinos Dean Boudoulas, MD, FSCAI
Ambulatory PCI
Discussion
How to Ensure Quality in the ASC Setting
Faisal Latif, M.D., FSCAI
Lessons Learned From Starting an ASC
Tony Das, M.D., FSCAI
Reimbursement and Coding for ASC Procedures
Yazan Khatib, M.D., FSCAI
The Rationale for Ambulatory PCI
Arnold H. Seto, MD, MPA, FSCAI
Welcoming Remarks
Lyndon Carlos Box, M.D., FSCAI
What Defines an ASC and What Procedures Can I Do?
Peter L. Duffy, M.D., FSCAI
An Update on Periprocedural Medical Therapy
Inhibit This: SGLT2 and PCSK9 Inhibitors in PAD
Marc P. Bonaca, MD, MPH
Post-PVI Pharmacotherapy: What to Use and What's the Right Duration?
Jun Li, M.D., FSCAI
The Current State of Supervised Exercise Therapy
Brett Carroll, MD
The Importance of Dual Pathway Inhibition in PAD
Connie N. Hess, M.D., FSCAI
Aorto-iliac, Visceral, and CFA Interventions: How to Advance Your Skillset
Aortoiliac Intervention: Access Site & Stent Selection
Peter Monteleone, M.D., FSCAI
CFA Intervention State of the Art
Maja Zaric, M.D.
EVAR: Newer Technology and Options
Andrew Unzeitig, MD
Mesenteric Ischemia: Assessment and Intervention
Mazen S. Abu-Fadel, M.D., FSCAI
When Transplanted Arteries Become a Problem: Case Selection and Treatment
Andrew J. Klein, M.D., FSCAI
Automation, AI, and Robotics—Leading Innovation in the Cath Lab
Advancing PCI Through Robotic Automation
Kathleen Kearney, M.D., FSCAI
Angio-Derived FFR: Changing the Physiology Paradigm
Ziad A. Ali, M.D., Ph.D.
CTO Intervention With Real-Time CT Fusion Guidance
Emmanouil S. Brilakis, MD, PhD, FSCAI
Future of Telemedicine and Remote PCI
Ryan D. Madder, M.D., FSCAI
Panel Discussion
Welcoming Remarks
Farouc A. Jaffer, M.D., Ph.D., FSCAI
Being the Best We Can Be
How to Handle Difficult Interactions With the Cath Lab Team
C. Michael C. Valentine, MD
How to Pick Up the Pieces After an Unfavorable Experience
Sohah Iqbal, M.D., FSCAI
Team Dynamics: How to Build a Collaboration and Positive Environment Within the Cath Lab
Frederick G. P. Welt, M.D., FSCAI
Updating Your Quality Assurance (QA) Program
Tamara M Atkinson, M.D.
Best of Coronary Complex Cases
Acute vessel closure solved using the retrograde approach
Yashasvi Chugh, MD, FSCAI
Case of Left Main Dissection Involving Whole Left Coronary Artery
Legate Philip, MBBS
Murphy’s Law in Left Anterior Descending Percutaneous Coronary Intervention
Judit Karacsonyi, MD, PhD
PCI of an Anomalous LCX CTO
Yashasvi Chugh, MD, FSCAI
Percutaneous Closure of an Iatrogenic Coronary Artery Fistula with a Covered Stent Using A Primary Retrograde Crossing Strategy
Katherine Kunkel, M.D., FSCAI
Tortuosity troubleshooting
Evangelia Vemmou, MD
Best of Peripheral Complex Cases
Acute No-Reflow Complicating Stenting of Severe Carotid Artery Stenosis
Aaron E. Brice, M.D.
Management of Idiopathic Infrarenal Aortic Dissection Presenting as Acute Limb Ischemia in a Young Female: A Case Report.
Darimireddi Siva KUMAR Kumar, MD, DM, CARDIOLOGIST, FSCAI
Multidisciplinary Approach to Pulmonary Vein Compression by an Enlarging Vertebral Osteophyte
Bogdan Kindzelski, MD, MSc
Persistence pays: An interventionally challenging case in a patient with a persistent left superior vena cava
Amel Tobaa, M.D.
The Novel Use of Retrograde Proximal Anterior Tibial Artery Access for treatment of TASC D Femoropopliteal Occlusion
Ahmad Z Arham, M.D.
Best of Structural Complex Cases
Explantation of an Implantable Left Ventricular Assist Device following Successful Percutaneous Repair of Severe Degenerative Mitral regurgitation
Junaid Mir, MD
Lacerating the barricade: A challenging case of TAVR/TMVR with concomitant LAMPOON and BASILICA procedures
Kirtivardhan Vashistha, M.D.
Percutaneous Mitral Valve Repair in Patient with Cardiogenic Shock Requiring Mechanical Circulatory Support.
Islam Shatla, MD
Severe mitral regurgitation in the setting of prior surgical mitral valve repair with Alfieri stitch treated with a vascular plug and a MitraClip
Katherine Rajotte, PA
Transcatheter Aortic Valve Implantation During Pregnancy
Pavan Thaneeru, MBBS
TRANSCATHETER CORRECTION OF SUPERIOR SINUS VENOSUS ATRIAL SEPTAL DEFECT(SVC ASD) WITH PPARTIAL ANAMOLOUS PULMONARY VENOUS DRAINAGE(PAPVC) USING AORTIC STENT GRAFT
Radhapriya Yalamanchi, MBBS, DNB Cardiology
Transcatheter Pulmonic Valve-in-Homograft Replacement in a Patient with Carcinoid Heart Disease
Rahul Sawhney, DO
Best of the Tip of the Month
How Low Can You Go? DAPT Duration and When to Switch in 2021
Faisal Latif, M.D., FSCAI
Paclitaxel for PAD: Tips on Safety and Patient Selection
Rajesh V. Swaminathan, M.D., FSCAI
#SafeFemoral Access: Using All the Tools in the Toolbox
Sridevi R. Pitta, M.D., FSCAI
Tips and Tricks for Invasive Assessment of Aortic Stenosis
Crispin H. Davies, MD
Tips on Taps: How to Use a Micropuncture Kit for Safe Pericardiocentesis
Lawrence Ang, M.D., FSCAI
When Nothing Goes Right, Go Left: Tips and Tricks for a Left Radial Approach
Kwan Seung Lee, M.D., FSCAI
CHD Abstracts and Late-Breaking Clinical Trials
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
International experience of 10 zig Covered CP stent correction of Sinus Venosus ASD
Eric Rosenthal, MD FRCP
In-Vitro Performance of Lifetech IBS Angel™ (Iron-based Bioresorbable Scaffold) Stents During Overdilation for Use in Pediatric Patients
Kurt R Bjorkman, MD
Long-term Outcomes of the Coarctation of the Aorta Stent Trials
Neil C Tailor, M.D.
Outcomes of Secundum Atrial Septal Defect Closure with the new GORE Cardioform ASD Occluder- Results from the Continued Access GORE ASSURED Clinical Trial
Athar M. Qureshi, M.D., FSCAI
PDA occlusion in very low birth weight (VLBW) infants: Comparing the Microvascular Plug and the Piccolo occluder
Frank F. Ing, M.D., MSCAI
Pre-Fontan Assessment Utilizing Combined Cardiac Catheterization and Cardiac MRI: Comparison to the Pre-Fontan Catheterization
Lindsay F Eilers, MD
The Harmony Transcatheter Pulmonary Valve: 1-Year Outcomes from the Pivotal Trial and 30-Day Outcomes from the Continued Access Study
Thomas K. Jones, M.D., MSCAI
The Impact of Patient Prosthesis Mismatch on the Outcome of Transcatheter Pulmonary Valve Implantation
Daiji Takajo, MD, MPH
Welcoming Remarks
CHD Community Forum
ACHA/SCAI Collaboration Update
Jamil A. Aboulhosn, M.D., FSCAI
Education/Webinar Update
Abhay A. Divekar, M.D., FSCAI
Helping Little Hearts Award: Recipient: Dr. Charles E. Mullins, MD, MSCAI
Frank F. Ing, M.D., MSCAI
Panel Discussion
QI Update
Lisa Bergersen, M.D., MPH, FSCAI
Research Update
Arash Salavitabar, M.D., FSCAI
SCAI.org Website Section Update
M. Elisabeth Leong, D.O.
COVID-19 in 2021: Interventional Perspectives
Approach to STEMI during COVID-19: Lessons from NACMI
Timothy D. Henry, M.D., MSCAI
Challenges of COVID-19: Next Wave, Vaccines, Future Directions
Celina M. Yong, M.D.
COVID's Impact on Interventional Cardiology Training
Robert J. Applegate, M.D.
COVID-19 and Cardiovascular Disease: An Overview
Ehtisham Mahmud, M.D., MSCAI
Discussion
International Perspective: Lessons Learned
Mamas A. Mamas, M.D., FRCP, FSCAI
Valvular Disease and COVID-19
Danny Dvir, M.D.
Welcoming Remarks
David A. Cox, M.D., MSCAI
CTO PCI: Get Comfortable Being Uncomfortable
CTO PCI: When It's Time to Call It Quits
Ashish Pershad, M.D., FSCAI
My Best and Worst ADR Cases: Lessons Learned
William J. Nicholson, M.D.
My Best and Worst Septal Retrograde Cases: Lessons Learned
Stéphane Rinfret, M.D., FSCAI
Cardiogenic Shock
Anticoagulation in Shock
Craig J. Beavers
Management of RV Shock
Babar B Basir, DO, FSCAI
Setting Up a SHOCK Program
Tara L. Jones, M.D., FSCAI
Understanding the Hemodynamics of Shock
Daniel Burkhoff, M.D., PhD
Carotid & Great Vessel Interventions: Present State & Future Directions
Nuances in Great Vessel Interventions: Case-Based Examples
Matheen A. Khuddus, M.D., FSCAI
Cases Over Cocktails
Does This Patient Need Transcatheter Aortic Valve Replacement or Medical Therapy? Challenges in Decision Making for Patients With Concomitant Aortic Stenosis and Heart Failure With Preserved Ejection Fraction.
Pranav Kansara, M.B.B.S., FSCAI
Impact on Instantaneous Wave-Free Ratio (IFR) on a Mildly Diseased Native Epicardial Vessel Supplying Collateral to the Contralateral Vessel Chronic Total Occlusion (CTO)—A Case Depicting the Change Before and After CTO Intervention.
Karthik Subramanian Anand, MD
LV Pseudoaneurysm Closure: Planning the Approach
Aaron Louis Strobel, M.D., FSCAI
Cath Lab Microeconomics and Macroeconomics
How to Survive Starting Up A Structural Heart Program
John D. Carroll, M.D.
Reimbursement: Are You Professional or Technical?
Harold L. Dauerman, M.D., FSCAI
Seeing Hazily Through a Crystal Ball: The Future of Health Care Reimbursement
Joel Sauer, MBA
Challenging Scenarios in the Cath Lab
Complete Revascularization in AMI: One-Stop Fix or Wait a Few Days!
Natalia Pinilla, MD, FSCAI
INOCA: Should Microvascular Testing Be Routine?
Nathaniel Rosso Smilowitz, MD, MSc
Clinical Cases That Challenge Ethical Boundaries
Case Presentation and Commentary: Utility vs. Futility – TTVR for Recurrent IVDU-Associated Endocarditis
Lee Eschenroeder, MD, James Kirkpatrick, MD
Case Presentation and Commentary: When Does Cognitive Impairment or Frailty Preclude the Benefit From TAVR?
Diana Carolina Otero Mostacero, MD, Megan Coylewright, M.D., FSCAI
Case Presentation: Difficult Decisions in Adults With Advanced Congenital Heart Disease?
Graham Bevan, MD
Case Presentation: To DO or Not to DO – Stenting in Patients With Uncertain Adherence and Financial Limitations
Mark Kardos Tuttle, M.D.
Commentary: Difficult Decisions in Adults With Advanced Congenital Heart Disease?
Jill Steiner, MD
Commentary: To DO or Not to DO – Stenting in Patients With Uncertain Adherence and Financial Limitations
Donald E. Cutlip, M.D., FSCAI
Complex Neonatal Palliation Case Presentations—Collaborations Across Disciplines
Discussion
Discussion
Discussion
Discussion
Infra-diaphragmatic TAPVR with Congenital Diaphragmatic Hernia: The Gut or The Heart: A Surgical Conundrum
Aamisha Gupta, M.D.
Modified Microvascular Plug as a Flow Restrictor in Hypoplastic Left Heart Syndrome with Dysplastic Tricuspid and Pulmonary Valves
Joshua David Kurtz, MD
Stenting of Ductus Venosus as a Palliation for Severe Portal Hypertension due to Congenital Hepatic Fibrosis.
Mats Steffi Jennifer, MD
Transjugular Ductus Venosus Stent Implantation in an Extremely Premature, 1 kg Neonate, With Infradiaphragmatic Total Anomalous Pulmonary Venous Connection
Julian E Cameron, MD
Welcoming Remarks
Controversies in Severe Aortic Stenosis
Controversy: Young People With Bicuspid Disease Deserve a Choice
Wah Wah Htun, M.D., FSCAI
Not All Low Risk Surgical Patients are Ideal for TAVR First: Small Annuli
Adnan K. Chhatriwalla, M.D., FSCAI
Patient Selection and Procedural Planning for Alternate Access
Jay S. Giri, MD, FSCAI
TAVR in the 65-75 Year Old: How Do You Choose?
Kimberly A. Skelding, M.D., FSCAI
Coronary Complications
Acute Occlusion and Dissection: Now What?
Tamara M Atkinson, M.D.
Discussion
Discussion
Discussion
Discussion
Discussion
Is That the Patient's Real Blood Pressure?
Ranya Sweis, M.D., FSCAI
PCI Problems: Help—I Can't Pull Gear Out!
Khaldoon Alaswad, M.D., FSCAI
Stent Woes: Loss and Underexpansion
Kevin J. Croce, M.D., Ph.D., FSCAI
Wait. Is That a Perforation?
Kenneth Yemisi Igbalode, MD, FACC, FSCAI
Welcoming Remarks
Duane S. Pinto, M.D., M.P.H.
Defining HBR: Leading the Way in High Bleeding Risk Patients
Acute MI With Left Main, Multi Vessel, and Anemia
Balbir Singh, MD
Defining High Bleeding Risk
Murugesh Shantaveeraya Hiremath, M.D.
Discussion
Discussion
Discussion
Live Case: Negotiating in HBR Patient From APOLLO Hospital, Visakhapatnam, India
Dibya Kumar Baruah, M.D.
Old Surgery, New Question?
Prakash Chandra Mondal, MD
Dual and Triple Therapy in the PCI Patient: A Moving Target
A Genotype-Guided Strategy for P2Y12 Inhibitors in PCI
Richard Gumina, MD, PhD
Anti-Platelet Therapy Post-PCI in Patients on an Oral Anti-coagulant: Too Much or Too Little?
Dharam J. Kumbhani, M.D., FSCAI
Aspirin vs. P2Y12 Inhibitor for Long-Term Therapy Upon Completion of DAPT Post-PCI
Dominick J. Angiolillo, M.D., FSCAI
Can Short DAPT Be Applied to the Patient With an Acute Coronary Syndrome?
Roxana Mehran, M.D., MSCAI
Discussion
Duration of Anti-Platelet Therapy for the Left Main Stent
Deepak L. Bhatt, M.D., M.P.H., MSCAI
Welcoming Remarks
Deepak L. Bhatt, M.D., M.P.H., MSCAI
Emerging Technologies in cPCI
Eliminating “Renalism”: A Review of Clinical Access, Procedural Risks, and Optimizing Care for Patients With CKD
Ziad A. Ali, M.D., Ph.D.
How to Perform Low & Ultra-Low Contrast PCI
Ashish Pershad, M.D., FSCAI
Low & Ultra-Low Contrast PCI for the Patient With CKD–—What Every IC Should Know
Jasvindar (Jas) Singh, MD, FSCAI
Panel Discussion
Putting It All Together, Case Example
Jasvindar (Jas) Singh, MD, FSCAI
The Value of a Cardio-Renal Program—What We Did and How It’s Working
Amir Kaki, M.D., FSCAI
Welcome and Introductions
Jasvindar (Jas) Singh, MD, FSCAI
FLASH & FLAME: Breaking New Ground in the Study of PE
Case Presentations: Pulmonary Embolism PE Cases
Michael A. Jolly, M.D., FSCAI
Introduction to Venous Thrombectomy Devices Inari Medical
Thomas M. Tu, M.D.
Review of the FLAME Study
Jay S. Giri, MD, FSCAI
Review of the FLASH Registry
Catalin Toma, M.D.
Featured Clinical Research: Acute Coronary and Cardiogenic Shock
Discussion
Discussion
Discussion
Discussion
Establishing the Optimal Duration of DAPT After PCI in High-Risk TWILIGHT-like patients with Acute Coronary Syndrome
Dr. Haoyu Wang
Final Results From The National Cardiogenic Shock Initiative
Babar B Basir, DO, FSCAI
SCAI Shock Classification for Mortality Risk Stratification: Survey of Published Evidence
Jacob C Jentzer, MD
Update on the North American COVID-19 Myocardial Infarction (NACMI) Registry
Payam Dehghani, MD
Featured Clinical Research: Stable Ischemic Heart Disease and TAVR
Comparison of the ISCHEMIA Trial Population to Patients Undergoing Percutaneous Coronary Intervention in US Practice: A Cathpci National Cardiovascular Data Registry (NCDR) Research to Practice (R2P) Initiative
Saurav Chatterjee, M.D., FSCAI
Safety and Efficacy of the Second Generation Robotic-Assisted System for Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION GRX Study
Ehtisham Mahmud, M.D., MSCAI
Socioeconomic and Geographic Access to Novel Therapeutics: An Analysis of Growth in Transcatheter Aortic Valve Replacement Programs
Ashwin Nathan, M.D.
The SMART Trial: Rationale and Design
Howard C. Herrmann, M.D., MSCAI
Featured Clinical Research: Vascular Access Closure and Coronary Interventions
Hospital-Level Percutaneous Coronary Intervention Performance with Simulated Risk Avoidance Strategies
Ashwin Nathan, M.D.
Radial hemostasis and early TR band deflation is safer and faster with a potassium ferrate hemostatic patch (Statseal): results from the randomized controlled Statseal with TR Band Assessment Trial 2 (STAT2).
Arnold H. Seto, MD, MPA, FSCAI
Femoropopliteal: “The Combat Zone” of Lower Extremities
DCB & DES: Where Should We Use It in 2021?
Eric Secemsky, MD, MSc, FSCAI
Discussion
Imaging for Femoropopliteal PAD: Is This the Future?
Ehrin J. Armstrong, M.D.
Radial or Pedal: Case-Based Equipment Selection
Beau M. Hawkins, M.D., FSCAI
Rock or No Rock: How Do I Select My Atherectomy?
Nicolas W. Shammas, MD, MS, FSCAI
SFA & Scaffolds: Avoid or Embrace?
Sasanka Jayasuriya, M.D., FSCAI
Welcoming Remarks
Faisal Latif, M.D., FSCAI
Fixing a Hole
Perivalvular Leak Closure of Both Surgical and Transcatheter Valves: Does the Type of Prosthetic Valve Make a Difference in the Approach and the Type of Device Utilized?
Tilak Pasala, MD, FSCAI
Forearm Access in Trans-Radial PCI
Alternate Forearm Access: The Future or a Niche?
Sanjay K. Chugh, M.D., DM Cardiology AIIMS New Delhi, FACC, FSCAI
Anatomic Challenges of Transradial PCI
Ranya Sweis, M.D., FSCAI
Management of Forearm Access Complications
Adhir R. Shroff, MD, FSCAI
Post-CABG: Can and Should We Still Be Radial?
Mirvat Alasnag, M.D., FSCAI
Radiation Safety in Radial Access
Sanjit S. Jolly, M.D.
Founders Lecture
The Successes, Challenges, and Boundless Potential of Structural Heart Intervention
James B. Hermiller, M.D., MSCAI
Global Case-Based Summit: Complex Interventions Without Borders
Approach To Treatment
Fazila T. N. Malik, M.B.B.S., FSCAI
Approach to Treatment
Hany I. Ragy, M.D., FSCAI
Complication: Case Presentation
Ahmed Magdy, M.D., Ph.D., FRCP(Glasgow), MSCAI
Complication: Case Presentation
Rafael Moguel, M.D., FSCAI
Complication: Case Presentation
M. Afzalur Rahman, M.D., FSCAI
Discussion
Discussion
Discussion
How They Treated
Bashir Hanif, M.D., FSCAI
Left Main Case Presentation
Mirvat Alasnag, M.D., FSCAI
Panel Discussion
Panel Discussion
STEMI Case Presentation
Bashir Hanif, M.D., FSCAI
Growing a Structural Program: Hot Topics in Structural Heart Disease
Disparities in Structural Heart Care: What Every Physician Needs to Know
Seun O. Alli, M.D., FSCAI
Structural Clinical Trials: Becoming a Research Site
Matthew James Daniels, M.D., Ph.D., FSCAI
The Rapidly Expanding Structural Heart Program: Inclusion, Respect, and Equity in the Cath Lab
Poonam Velagapudi, MD MS, FSCAI
Upcoming Structural Trials You Do Not Want to Miss
Chandan Devireddy, M.D., FSCAI
Health and Safety in the Cath Lab
Glowing Naturally: Radiation Safety in the Cath Lab
Paul Fiorilli, M.D.
Hemodynamic Brain Teasers
Determining a Hemodynamically Successful Mitral Clip: When MR Is Still Present but the Left Atrial Pressure Improves
Molly Szerlip, M.D., FSCAI
Hypertrophic Cardiomyopathy
Morton J. Kern, M.D., MSCAI
High-Risk Scenarios and Prevention of Complications
Avoiding Coronary Artery Perforation and How to Manage When They Occur
Yader B. Sandoval, M.D., FSCAI
Minimizing Risk for Aortocoronary Dissection in the Cath Lab and How to Manage When They Occur
Konstantinos Charitakis, MD, FSCAI
Optimizing Femoral Access in a Radial First Lab
Javier Alfonso Valle, MD, MSCS, FSCAI
Patient With a Recent Stroke: Is It Safe to Go to the Cath Lab and if so, When?
Deepali Nivas Tukaye, M.B.B.S., FSCAI
Processes to Prepare Staff for the Management of Cath Lab Disasters
Joaquin E. Cigarroa, M.D., MSCAI
Hildner Lecture
Black Lives Matter…In the Cath Lab, Too! A Role for Interventional Cardiology in Combating Racism
Quinn Capers IV, MD
Welcoming Remarks
Daniel M. Kolansky, M.D., FSCAI
I Blew It!
Case: Hmmm; I Don't Think This Will Ever End!
Howaida El-Said, M.D., Ph.D., FSCAI
Case 1 and Discussion
Srinath T. Gowda, M.D.
Case 2 and Discussion
Daniel Mclennan, M.B.B.S.
Case 3 and Discussion
Shyam K. Sathanandam, M.D., FSCAI
Case 4 and Discussion
Brian H. Morray, M.D., FSCAI
Case 6 and Discussion
Dr. Paul Tannous, M.D., Ph.D., FSCAI
Welcoming Remarks
Imaging and Physiology
Challenges in Coronary Physiology
Arnold H. Seto, MD, MPA, FSCAI
Discussion
IVUS: The Why, When, and How?
Eric A. Osborn, M.D., Ph.D., FSCAI
Noninvasive FFR: The Why, When, and How?
Morton J. Kern, M.D., MSCAI
The ABCs of OCT
S. Elissa Altin, M.D., FSCAI
The Case for Invasive Physiology
Allen Jeremias, M.D.
Welcoming Remarks
William F. Fearon, M.D., FSCAI
Impact of COVID-19 on Cardiology: International Perspectives
Panel Discussion
The Brazilian and Latin American Experience
Marcelo José De Carvalho Cantarelli, M.D., Ph.D., FSCAI
The Egyptian Experience
Hany I. Ragy, M.D., FSCAI
The Italian and European Experience
Marta Bande, M.D., FSCAI
The Pakistani and South Asian Experience
Bashir Hanif, M.D., FSCAI
The US and North American Experience
Binita Shah, M.D., FSCAI
Insights and Implications on Reduction of Ischemic Events With Eicosapentaenoic Acid
Cardiovascular Outcomes Trials of Omega-3 Fatty Acids in ASCVD
Deepak L. Bhatt, M.D., M.P.H., MSCAI
Mechanistic Clues to Omega-3 Fatty Acid CV Benefits: Focus on Coronary Plaque Regression and Stabilization
Matthew J. Budoff, M.D.
Panel Discussion
Welcome and Opening Remarks
C. Michael Gibson, M.D., MSCAI
Intravascular Lithotripsy for Treatment of Complex Coronary Lesions
Expanded Use and Post-Market Studies
Jonathan Michael Hill, M.D.
IVL Complex Coronary Case Examples
Robert F. Riley, M.D., FSCAI
IVL Coronary Clinical Trials
Dean J. Kereiakes, M.D., MSCAI
Panel Discussion
Welcoming Remarks
Dean J. Kereiakes, M.D., MSCAI
LAA/PFO: Stroke Prevention in Interventional Cardiology
Case Selection for LAAC: New Indications and New Devices
Jacqueline Saw, M.D., FSCAI
CT Imaging in LAAC Case Selection, Procedural Planning, and Follow-Up
Dee Dee Wang, M.D., FSCAI
Discussion
ICE: Transseptals and PASS Criteria
Mohamad Alkhouli, M.D., FSCAI
PFOs: A Neurologist's Perspective on Patient Selection
David E. Thaler, M.D., Ph.D.
PFOs: They Are Not All the Same – Be Prepared!
John M. Lasala, M.D., Ph.D., MSCAI
Welcoming Remarks
Molly Szerlip, M.D., FSCAI
Left Main & Coronary Bifurcation Summit (CBS)—SCAI Bifurcation Club Partnership Session
Discussion
Keynote: Comparing PCI and CABG in Left Main Disease
Gregg W. Stone, M.D.
Live Case from Nanjing First Hospital, Nanjing Medical University
Shao-Liang Chen Sr., M.D., Ph.D., Junjie Zhang, M.D., FSCAI, Tao Pan
Live Balloon Pulmonary Angioplasty (BPA) for CTEPH Case from the Massachusetts General Hospital
Live Balloon Pulmonary Angioplasty (BPA) for CTEPH Case from the Massachusetts General Hospital
Kenneth Rosenfield, M.D., MHCDS, MSCAI
Live Complex Coronary Case From Henry Ford Hospital
Live Complex Coronary Case From Henry Ford Hospital
William W. O'Neill, MD, MSCAI, Brian O'Neill, MD
Live Coronary CTO Case From Emory University Hospital
Live Coronary CTO Case Emory University Hospital
William J. Nicholson, M.D., Wissam A Jaber, M.D., FSCAI
Live Coronary Double RCA CTO and LAD Case from the Massachusetts General Hospital
Live Coronary Double RCA CTO and LAD Case from the Massachusetts General Hospital
Farouc A. Jaffer, M.D., Ph.D., FSCAI
Live Structural Case From Henry Ford Hospital
Live Structural Case From Henry Ford Hospital
Marvin H. Eng, M.D., FSCAI, James Lee, M.D.
Live Structural LAAO Case From Emory University Hospital
Live Structural LAAO Case from Emory University Hospital
Adam Greenbaum, M.D.
Live Structural TAVR Case From Baylor University Medical Center
Live Structural TAVR Case From Baylor University Medical Center
Molly Szerlip, M.D., FSCAI, Katherine Brooks Harrington, M.D.
Live Structural Transcatheter Edge-to-Edge Mitral Repair (TEER) Case From University of California, Davis Health
Live Structural Transcatheter Edge-to-Edge Mitral Repair (TEER) Case from University of California, Davis Health
Jason H. Rogers, M.D., FSCAI
Looking at the Acute Decompensated Heart Failure (ADHF) Patient in Cardiogenic Shock
Acutely Decompensated Heart Failure (ADHF) and Cardiogenic Shock: Fundamental Principles
Navin K. Kapur, M.D., FSCAI
Case Presentation
Jaime Hernandez-Montfort, MD MPH MSc
Clinical Data Evaluating the Use of Acute MCS in ADHF
A. Reshad Reshad Garan, MD
Design and Rationale for the Alt-Shock Trial
Nuccia Morici
Mechanistic Rationale for Acute MCS Device Selection in Advanced Heart Failure
Jennifer Cowger, MD
Panel Discussion
Panel Discussion
Shock Algorithms Tailored to the Patient With Advanced Heart Failure
Haval Chweich
Welcoming Remarks
Navin K. Kapur, M.D., FSCAI
Managing Cardiogenic Shock: A Case-Based Approach
Acute MI Cardiogenic Shock—Case Conclusion
Katherine Kunkel, M.D., FSCAI
Acute MI Cardiogenic Shock—Case Presentation
Katherine Kunkel, M.D., FSCAI
Cardiac Intensive Care Unit Shock Management: Best Practices
Timothy D. Smith, M.D., FSCAI
Discussion
Introduction
Alexander G. Truesdell, M.D., FSCAI
RV Failure, Escalation, and Futility
A. Reshad Reshad Garan, MD
Shock Protocols, Shock Teams, Shock Centers, and Shock Networks
Behnam N. Tehrani, M.D.
Mitral Fundamentals: Repair and Replacement
Knowing the Essentials of CTA for TMVR
Tiffany Chen, MD
Percutaneous Leaflet Plication MitraClip/PASCAL: How to Optimize Outcomes And Understanding Device Nuances
Molly Szerlip, M.D., FSCAI
Mitral Valve Repair
Considerations for a Failed Surgical MVRe: Role of Percutaneous Technologies
Kendra J. Grubb, M.D.
Degenerative MR in Complex Anatomy: Dealing With Lateral/Commissural MR and Calcified Leaflets
Ruby Satpathy, M.D., FSCAI
Discussion
Mitral Valve Repair: Anatomic Considerations and Essentials of Imaging
Omar Khalique, M.D., FSCAI
Refining Approach to Functional MR for the Complex Patient—Low EF/Shock
Santiago Garcia, M.D., FSCAI
Welcoming Remarks
Paul Sorajja, M.D., FSCAI
Mitral Valve Replacement
Adjunctive Therapies: LAMPOON, VAMPOON, Septal Ablation
Jaffar M Khan, MD, PhD, FSCAI
Approaches to Mitral Regurgitation: TEER vs. TMVR
Jason H. Rogers, M.D., FSCAI
Discussion
Expanding Use of TMVR in Mitral Stenosis Associated With MAC
Paul Sorajja, M.D., FSCAI
Optimizing Outcomes in Valve-in-Valve and Valve-in-Ring
Mayra E. Guerrero, M.D., FSCAI
TMVR: Device Selection in MR
Howard C. Herrmann, M.D., MSCAI
Welcoming Remarks
Howard C. Herrmann, M.D., MSCAI
Modern Day Management of Aortic Stenosis in Younger Patients
Anatomical Considerations
James B. Hermiller, M.D., MSCAI
How to Use Echo in Long Term Monitoring of Valve Function?
Amr E. Abbas, M.D., FSCAI
Panel Discussion
SAVR or TAVR First? A Case-Based Discussion
Suzanne J. Baron, M.D., FSCAI
Social Factors and Patient Preference and Key Takeaways from Guidelines and the Heart Team Approach
Megan Coylewright, M.D., FSCAI
Welcome and Introductions
James B. Hermiller, M.D., MSCAI, Mark J. Russo, M.D., David A. Wood, M.D., FSCAI
Mullins Lecture
Pediatric & Congenital Interventional Cardiology: A 21st Century Team Sport. Building and Leading Successful Interventional Teams
Julie A. Vincent, MD
Welcoming Remarks
Jacqueline Kreutzer, M.D., FSCAI
My Wish List
Welcoming Remarks
Daniel H. Gruenstein, M.D.
Wish List Idea: Flexible PDA Stent
James A. Thompson, M.D., FSCAI
Wish List Idea: Retrievable Stent
Gregory A. Fleming, M.D., FSCAI
PICES Session: Thinking Outside of the Box—Collaborating With Non-CHD Specialists
Case Presentation
Peter W. Guyon Jr., M.D.
Case Presentation
Rachel Alison Taylor, M.D.
Case Presentation
R. Allen Ligon Jr., MD, FSCAI
Discussion
Discussion
Discussion
Discussion
How We Built This Fetal Interventional Program
Henri Justino, M.D., FSCAI
PediHeart Podcast With Dr. Robert Pass, Session 1
The Podcast I Should Have Done: Transcatheter Correction of Superior Sinus Venosus Atrial Septal Defects as an Alternative to Surgical Treatment—Author Presentation
Eric Rosenthal, MD FRCP
The Podcast I Should Have Done: Transcatheter Correction of Superior Sinus Venosus Atrial Septal Defects as an Alternative to Surgical Treatment—Interview
Eric Rosenthal, MD FRCP, Robert H. Pass, M.D., FSCAI
The Podcast I Wish I Could Have Done: Interview with Julie Vincent and Chuck Mullins
Robert H. Pass, M.D., FSCAI, Charles E. Mullins Sr., M.D., Julie A. Vincent, MD
Welcoming Remarks
Aimee K. Armstrong, M.D., FSCAI
PediHeart Podcast With Dr. Robert Pass, Session 2
My Favorite Podcast From the Last Year: Can Ductus Arteriosus Morphology Influence Technique/Outcome of Stent Treatment?—Author Presentation
Marc Gewillig, M.D.
My Favorite Podcast From the Last Year: Can Ductus Arteriosus Morphology Influence Technique/Outcome of Stent Treatment?—Interview
Marc Gewillig, M.D., Robert H. Pass, M.D., FSCAI
The Podcast I’m Most Looking Forward to in the Coming Year: Balloon Angioplasty for Native Aortic Coarctation in 3- to 12-Month-Old Infants—Author Presentation
Rajiv R Chaturvedi, M.D.
The Podcast I’m Most Looking Forward to in the Coming Year: Balloon Angioplasty for Native Aortic Coarctation in 3- to 12-Month-Old Infants—Interview
Rajiv R Chaturvedi, M.D., Robert H. Pass, M.D., FSCAI
Welcoming Remarks
Aimee K. Armstrong, M.D., FSCAI
Peripheral Vascular Disease Complications
Bailout Techniques: What You Must Know!
George L. Adams, M.D.
Dealing With MCS Complications: Bailing Your Colleagues Out!
S. Elissa Altin, M.D., FSCAI
My Worst Iliac Intervention
Peter A. Soukas, M.D., FSCAI
Peripheral Vascular Disease: A Year In Review
Impact From COVID: Disruption to PVD
Christine J. Chung, M.D.
My Top Practice-Changing Guidelines of 2020
Khanjan Shah, MD MPH
My Top Three Observational Studies of the Year
Herb D. Aronow, MD, MPH, FSCAI
My Top Three Randomized Clinical Trials of the Year
Eric Secemsky, MD, MSc, FSCAI
Planning for Success in High-Risk PCI
Access and DAPT: Tailoring to the HBR Patient
Jennifer A. Tremmel, M.D., FSCAI
CTO Skill Sets Save the Day in Complex PCI
Emmanouil S. Brilakis, MD, PhD, FSCAI
Discussion
Hemodynamic Support in Complex PCI
Ajay J. Kirtane, M.D., FSCAI
SCAI Position Statement on Complex PCI: The Need of the Hour
Robert F. Riley, M.D., FSCAI
The Heart Team Approach to Complex PCI
Farouc A. Jaffer, M.D., Ph.D., FSCAI
Welcoming Remarks
Cindy L. Grines, M.D., MSCAI
Planning for Success of Complex Interventions in the Cath Labs of Today and Tomorrow
Case: Complex Coronary Atherectomy and Same Day Discharge
Megan Toole, MD
DEBATE: Complex Coronary Interventions and ASCs: Not Ready for Primetime, Yet
Arasi Maran, M.D., FSCAI
DEBATE: Complex Coronary Interventions in ASCs: Can It Be Done Safely?
Georges Y. Nseir, M.D.
Discuss SCAI Position Statement on Performing PCI in Ambulatory Surgery Centers
Deepali Nivas Tukaye, M.B.B.S., FSCAI
Lessons Learned: Complex Vascular Procedures in OBLs
Jeffrey G. Carr, M.D., FSCAI
Panel Discussion
Welcome and Introductions
Adhir R. Shroff, MD, FSCAI
Polyvascular Disease: What Is Optimal Medical Therapy Following Peripheral Revascularization?
Antithrombotic Agents for Patients With Polyvascular Disease: Before and After Peripheral Vascular Intervention
Marc P. Bonaca, MD, MPH
How Do We Identify Patients With Polyvascular Disease, and What Are the Outcomes of Polyvascular Disease?
Ehrin J. Armstrong, M.D.
Panel Discussion
Treatment of Carotid, Coronary, and Peripheral Artery Disease in a Single Patient: How to Manage?
Herb D. Aronow, MD, MPH, FSCAI
Welcoming Remarks
Ehrin J. Armstrong, M.D.
What Is the Role of SGLT2 and PCSK9 Inhibitors for Patients With Polyvascular Disease?
William Schuyler Jones, M.D.
President's and Program Chair's Welcome
Presidential Address by Cindy Grines, MD, MSCAI
Cindy L. Grines, M.D., MSCAI
SCAI Award Presentation: Mason Sones Distinguished Service Award
Cindy L. Grines, M.D., MSCAI
SCAI Award Presentations: Helping Hearts Lifetime Service Award, Helping Little Hearts Lifetime Service Award
Cindy L. Grines, M.D., MSCAI
Welcome by 2021 Program Chair
Daniel M. Kolansky, M.D., FSCAI
Protected PCI: Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-Term Outcomes
Efficacy of Extensive Revascularization at Index PCI With Impella Support
Ehtisham Mahmud, M.D., MSCAI
“I really should have used support.” A Case-Based Approach to Patient Identification
Duane S. Pinto, M.D., M.P.H., Laurette Mbuntum, MD
Patient Identification: Appropriate Patient Selection
Rajan A. Patel, M.D., FSCAI
Protect IV: New Data Supporting Complete and Supported Revascularization
Gregg W. Stone, M.D.
Skills and Tools Required for Complete and Safe Revascularization
Alejandro Lemor, M.D., FSCAI
Welcoming Remarks
Duane S. Pinto, M.D., M.P.H.
Quality Improvement Tools
Contrastless Delivery: Protocols and Strategies for Minimizing Contrast Use
Tai Kobayashi, M.D., FSCAI
Same-Day Discharge: WIN, WIN, WIN Situation
Arnold H. Seto, MD, MPA, FSCAI
Reduction of Recurrent Strokes in Patients with PFO: Long-Term Outcomes
Background Discussion on PFO and Stroke Prevention; REDUCE Results (Median of 3.2 Years); REDUCE Results (Median of 5 Years); PFO Closure Patient Selection and Treatment Practices
Matthew J. Price, MD, Robert J. Sommer, M.D.
SCAI Bifurcation Club: Approaches to Left Main PCI
Choosing the Right Double-Stent Strategy
David E. Kandzari, M.D., FSCAI
Deconstructing the Double-Stent Strategy
Kathleen Kearney, M.D., FSCAI
Left Main Intervention: A Decade in Review
Mauricio G. Cohen, M.D., FSCAI
Not All Left Mains Are Created Equal
Wayne B. Batchelor, M.D., FSCAI
Single-Stent Strategy: Less Is More
Annapoorna S. Kini, M.D.
The Crucials of UPLM PCI: Deep Dive Into Imaging and POT
Jasvindar (Jas) Singh, MD, FSCAI
Welcoming Remarks
Annapoorna S. Kini, M.D.
SCAI Clinical Documents
Discussion
Position Statement on Competencies and Training Program Requirements for Revascularization Specialists Providing CLTI Care
Beau M. Hawkins, M.D., FSCAI
SCAI Cath Lab Best Practices Update
Srihari S. Naidu, MD, FSCAI
SCAI Expert Consensus Statement on Sex-Specific Considerations for Myocardial Revascularization
Alexandra J. Lansky, M.D., MSCAI
SCAI International Case Exchange
A Complex NSTEMI Case: Which is the Culprit Lesion?
Jose L Leiva Pons Sr., M.D.
Calcified Lesions Case Presentation
James Nguyen, M.D.
How I Would Treat
Rami N. Khouzam, M.D., FSCAI
How the Case Unfolded
José Mangione, PhD
How the Case Unfolded
James Nguyen, M.D.
How They Treated
Jose David Tafur Soto, M.D.
How They Treated
Jose L Leiva Pons Sr., M.D.
Left Main Case Presentation
Jose David Tafur Soto, M.D.
Panel Discussion
Panel Discussion
Panel Discussion
Panel Discussion
STEMI Case Presentation
José Mangione, PhD
Welcoming Remarks
Ramesh Daggubati, M.D., FSCAI
SCAI Women in Innovations (SCAI-WIN): Coronary, Structural, and Peripheral Interventions
Case Presentation
Kathleen Kearney, M.D., FSCAI
Case Presentation
Vivian Gar-Yan Ng, M.D., FSCAI
Case Presentation
J. Dawn Abbott, M.D., FSCAI
Discussion
Discussion
Discussion
Getting out of Hot Water: Tips and Tricks for Handling Coronary Complications
Ki E Park, M.D., FSCAI
Managing Large Bore Access and Complications
Sasanka Jayasuriya, M.D., FSCAI
Transcatheter Options for Mitral Valve Regurgitation: Evaluation Considerations and New Technology
Mayra E. Guerrero, M.D., FSCAI
SCAI Women in Innovations (SCAI-WIN): Structural Heart Disease and Interventions
Case Presentation: Transcatheter Pulmonary Valve Replacement
Molly Szerlip, M.D., FSCAI
Transcatheter Pulmonary Valve Replacement: New Technology
Joanna Ghobrial, M.D., FSCAI
SCAI-PICS Collaboration Session: Taped Case
Live Case from The Children's Hospital of Philadelphia
Jonathan J. Rome, M.D.
Panel Discussion
State of the State: Using Society Documents to Guide Your Practice
Aorto-iliac Disease: Incorporating SCAI Guidelines on Device Selection
Dmitriy N. Feldman, M.D., FSCAI
Below the Knee: Where Do Technology & Guidelines Meet?
Khusrow A. Niazi, M.D., FSCAI
Femoral Popliteal Disease: SCAI Document on Device Selection
Jennifer A Rymer, MD, MBA, MHS
Stuck Between a Rock and a Hard Place: Get Unstuck
Algorithmic Approach to Intracoronary Calcium
Triston B. B. J. Smith, M.D., FSCAI
Atherectomy: Learn One Technique or All?
Nadia R. Sutton, M.D., M.P.H., FSCAI
Balloons and IVL: Tips & Tricks
Megha Prasad, M.D.
Discussion
The (Sometimes) Ugly Side of Atherectomy
Dr. Prashant Kaul, M.D., FSCAI
Vessel Preparation Is the Key to Success
Sara Cecilia Martinez, M.D., Ph.D., FSCAI
Welcoming Remarks
Binita Shah, M.D., FSCAI
TAVR Fundamentals
Stroke Prevention With Cerebral Protection: Emerging Approaches
Chad Kliger, M.D., FSCAI
The Basics of Device Selection in TAVR
Marvin H. Eng, M.D., FSCAI
Transfemoral When Iliofemorals Are Small: Step-by-Step Strategies for Success
Saif Anwaruddin, M.D.
TAVR Fundamentals: Tips and Tricks
Best Practices in Complex Valve in Valve
Adam Greenbaum, M.D.
Discussion
Stroke Prevention: Use Now or Gather More Data?
Samir Ramesh Kapadia, M.D., FSCAI
TAVR in Young Patients: Potential Harms
Tamim M. Nazif, M.D., FSCAI
Valve Selection: For Today and Tomorrow
Suzanne J. Baron, M.D., FSCAI
Welcoming Remarks
Steven J. Yakubov, M.D., MSCAI
Young People With Bicuspid Disease: What Is the Best Therapy?
Basel Ramlawi, MD
Tackling Large Bore Access
Access Using Multimodality Imaging: Tips and Tricks
Chad Kliger, M.D., FSCAI
Complications and Closure
Santiago Garcia, M.D., FSCAI
Limb Protection Strategies After Large Bore Access
Rhian E. Davies, DO MS, FSCAI
The Best of Catheterization and Cardiovascular Interventions
Application of the SCAI Classification in a Cohort of Patients With Cardiogenic Shock
Dirk Westermann, MD
Considerations for Cardiac Catheterization Laboratory Procedures During the COVID-19 Pandemic Perspectives From the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates
Molly Szerlip, M.D., FSCAI
Discussion
Discussion
The Impact of Pre-Existing Peripheral Artery Disease on Transcatheter Aortic Valve Implantation Outcomes: A Systematic Review and Meta-Analysis
Giuseppe Tarantini, MD, PhD
The CLI Toolbox: From Access Site to Scaffolds
Approach to Access Selection in CLI: When and How?
Larry J. Diaz, M.D., FSCAI
Discussion
Drug Therapy and CLI: Safety First, but Is It Effective?
Jun Li, M.D., FSCAI
How to Optimize Wound Healing
Lawrence A. Garcia, M.D., FSCAI
Pedal Loop Intervention: Best and Worst Cases
Mehdi H. Shishehbor, D.O., MPH, PhD, FSCAI
Welcoming Remarks
Eric Secemsky, MD, MSc, FSCAI
The Future Is Upon Us: Emerging Technology and PVI
Addressing the Unaddressed: PQ Bypass and Deep Vein Arterialization for Limb Salvage
Fadi A. Saab, M.D., FSCAI
Atherectomy, Lithotripsy, Thrombectomy, and More
Jay S. Mathews, MD, FSCAI
Round 2: Is Renal Denervation Here to Stay?
David E. Kandzari, M.D., FSCAI
Seeing Is Believing: From IVUS to OCT to FORS
Joseph Campbell, M.D.
What's New in Vascular Scaffolds?
Peter Monteleone, M.D., FSCAI
The Vascular Team: How to Build It!
Comprehensive Vascular Care: How to Divide and Conquer as a Team
S. Elissa Altin, M.D., FSCAI
How to Start a Vascular Practice: A Primer
Christopher J. White, M.D., MSCAI
Office-Based Labs: Past, Present, and Future
Eric J Dippel, M.D., FSCAI
Reaching Cross-Disciplinary Consensus on Privileging
Subhash Banerjee, M.D., FSCAI
Town Hall SCAI Highlights, MSCAI & FSCAI Inductions, and Timothy D. Henry, MD, MSCAI, Presidential Inauguration
FSCAI Inductions
Ronald P. Caputo, M.D., MSCAI
MSCAI Inductions
Cindy L. Grines, M.D., MSCAI
Presidential Address
Timothy D. Henry, M.D., MSCAI
Town Hall SCAI Highlights
Cindy L. Grines, M.D., MSCAI, Timothy D. Henry, M.D., MSCAI, Sunil V. Rao, MD, FSCAI, George D. Dangas, M.D., Ph.D., MSCAI, Peter L. Duffy, M.D., FSCAI, Ehtisham Mahmud, M.D., MSCAI
Transition of Leadership
Cindy L. Grines, M.D., MSCAI
Transcatheter Pulmonary Valve Replacement (TPVR): Latest Cases and Data
Case Presentation: The Harmony Transcatheter Pulmonary Valve
Doff B. Mcelhinney, M.D., FSCAI
Historical Perspective and Current State of the Art in Transcatheter Pulmonary Valve Replacement
John P. Cheatham, M.D., MSCAI
Panel Discussion
The Harmony Transcatheter Pulmonary Valve: Patient Screening and Implant Procedure
Daniel S. Levi, M.D., FSCAI
Welcome and Introductions
Matthew J. Gillespie, M.D., FSCAI
Tricuspid Valve Repair and Replacement
Discussion
Is TTVR the Future of Tricuspid Valve Therapy?
James B. Hermiller, M.D., MSCAI
Knowing the Essentials of Tricuspid Valve Imaging
Rebecca Tung Hahn, M.D.
Percutaneous Leaflet Plication: How to Optimize Outcomes
Mackram F. Eleid, M.D., FSCAI
Percutaneous Tricuspid Annuloplasty: How to Optimize Outcomes
William Anthony Gray, M.D., FSCAI
Welcoming Remarks
Susheel K. Kodali, M.D.
What Are the Biggest Challenges When Expanding Into the Tricuspid Valve Space?
Azeem Latib, M.D., FSCAI
Uncomplicating the Complex
Advanced Wiring Tips for Difficult Anatomy
Robert W. Yeh, M.D., FSCAI
Case-Based Approach to Non-Left Main Bifurcations
Jay Bagai, M.D., FSCAI
Coronaries Behind Bars: Post-TAVR PCI
David Zidar, M.D., Ph.D., FSCAI
Discussion
The Recurrent Restenosis Blues
Sarah Zaman, M.D.
The Ups and Downs of Tortuosity
Hady Lichaa, MD, FACC, FSCAI
Welcoming Remarks
Ronald P. Caputo, M.D., MSCAI
Venous Interventions
Beyond the Veins: Lymphedema and How to Get Trained in 2021!
Brett Carroll, MD
Iliofemoral DVT: Is CDT for This Dead? Trial Comparisons
Tai Kobayashi, M.D., FSCAI
Superficial Venous Disease: Is It Really Superficial? Is It Necessary to Know? How Do We Know?
Walid S. Saber, M.D., FSCAI
Venous CTO: The Final Frontier? When Should we Think of Opening Them?
Frank J. Arena, M.D., FSCAI
Venous Thromboembolism (PE/DVT)
A CTEPH Center: Who, What, and How?
Ehtisham Mahmud, M.D., MSCAI
Comparison of Catheter-Directed (EKOS) vs. Infusion Catheter vs. Low-Dose Intravenous Thrombolysis for Submassive PE
Alison Witkin, MD
Discussion
IVC Filters: Who, When, and Why?
Tai Kobayashi, M.D., FSCAI
Massive PE-ECMO, TPA, CDT: What, When, and How?
Jay S. Giri, MD, FSCAI
Thrombectomy for PE: What, When, and How?
Mitchell Weinberg, M.D., FSCAI
Welcoming Remarks
Kenneth Rosenfield, M.D., MHCDS, MSCAI